Holburn Group of Companies is committed to its strategic
vision of growth and profitability. Our focus
is on leading-edge biomedical R&D programmes,
to which we dedicate significant human and financial resources.
To accommodate Holburn's growth and to create an environment in which biotechnology and pharmaceutical opportunities can be realized, Holburn has undertaken the development of a Science Park. The first phase, a 40,000 square foot state-of-the-art science facility, was completed in late 2006. The planning for phase II of the project has already begun.
this growth and development, Holburn is seeking investors
and partners for direct investment and collaboration.
For information on investment and development opportunities e-mail us by clicking
here or write to:
Ronald H. Stead
The Holburn Group of Companies
1100 Bennett Road
Bowmanville, Ontario, Canada